ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Cancer survivors number 9.8 million in U.S., CDC says.

June 25, 2004

Two Court Rulings Conflict In Paclitaxel Patent Battle.

January 18, 2002

ACCC Annual Meeting Expands to 4 Days, One On Cancer Control

January 15, 1982

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000

Kidney Cancer Group Seeks Proposals; AACR Offers Award

November 17, 1995